With the over-representation of racial and ethnic minority (REM) populations in HIV/AIDS, there is a need to recruit and mentor REM scientists involved in neuroAIDS investigations. The Mount Sinai Institute for NeuroAIDS Disparities (MSINAD) will stimulate entry and retention of REM and non-REM scientists working in the field of neuroAIDS disparities. This institute offers a multi-disciplinary curriculum spanning the fields of neurology, neuropsychology, psychiatry, neuropathology, and neuroscience. Selected scholars are given both didactic seminars and a research practicum;didactics cover both topics germaine to neuroAIDS disorders, and general tools for academic success, including grant development. Scholars are matched with both a scientific and a development mentor, and have access to a multi-disciplinary panel of senior scientists as well as junior faculty in AIDS disparities research as role models. By summer's end, scholars gain a strong grounding in topics necessary to conduct high quality, multi- disciplinary translational neuroAIDS research in REM communities. The MSINAD builds upon the infrastructures of two programs. The Manhattan HIV Brain Bank is a multi-disciplinary research resource that maintains an HIV-positive REM cohort that undergoes longitudinal neurologic, neuropsychologic, and psychiatric assessments. It routinely interacts with and supports a variety of neuroscientists investigating HIV manifestations and neuropathogenesis, has conducted pilot analyses of neuroAIDS disparities, and has successfully recruited and trained minority investigators who are entering the neuroAIDS research work force. The Mount Sinai Center for Multicultural and Community Affairs is a Center of Excellence for Minority Health, focused on reducing REM health outcome disparities by developing increased health care work force diversity, and providing support services at a variety of educational training and practice levels. Its Faculty Development Programs support minorities in a variety of research and clinical career pathways. By combining the unique strengths of these two programs, the MSINAD creates high quality, REM researchers whose long term careers will make a lasting contribution to the area of neuroAIDS disparities.
As HIV/AIDS disproportionately impacts minority communities, it is imperative to generate a research workforce capable of investigating HIV-related nervous system disorders in culturally and scientifically appropriate manners. MSINAD has been created to recruit, train, mentor, and support the talents of young scientists interested in neuroAIDS disparities research, with a focus on REM investigators. MSINAD programs seek to improve the quality of research into neuroAIDS disorders.
|Walker, Keenan A; Brown, Gregory G (2018) HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis. J Clin Exp Neuropsychol 40:357-376|
|Clark, Uraina S; Arce Rentería, Miguel; Hegde, Rachal R et al. (2018) Early Life Stress-Related Elevations in Reaction Time Variability Are Associated with Brain Volume Reductions in HIV+ Adults. Front Behav Neurosci 12:6|
|Hunter, Madeleine D; Shenoy, Adele; Dwork, Andrew et al. (2018) Brain vascular intima vulnerability among HIV-positive and negative individuals. AIDS 32:2209-2216|
|Gutierrez, Jose; Murray, Jacinta; Chon, Christina et al. (2018) Relationship between brain large artery characteristics and their downstream arterioles. J Neurovirol 24:106-112|
|Kuhn, Taylor; Kaufmann, Tobias; Doan, Nhat Trung et al. (2018) An augmented aging process in brain white matter in HIV. Hum Brain Mapp 39:2532-2540|
|Veenstra, Mike; Byrd, Desiree A; Inglese, Matilde et al. (2018) CCR2 on Peripheral Blood CD14+CD16+ Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs? J Neuroimmune Pharmacol :|
|Calderon, Tina M; Williams, Dionna W; Lopez, Lillie et al. (2017) Dopamine Increases CD14+CD16+ Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. J Neuroimmune Pharmacol 12:353-370|
|Obermeit, Lisa C; Beltran, Jessica; Casaletto, Kaitlin B et al. (2017) Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining ""symptomatic"" versus ""asymptomatic"" HAND. J Neurovirol 23:67-78|
|Roth, William; Morgello, Susan; Goldman, James et al. (2017) Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging. Stroke 48:638-644|
|Clark, Uraina S; Sweet, Lawrence H; Morgello, Susan et al. (2017) High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav 11:649-665|
Showing the most recent 10 out of 110 publications